四川双马：关于控股子公司湖北健翔获得俄罗斯GMP证书的公告

Core Points - Sichuan Shuangma announced that its subsidiary Hubei Jianxiang Biopharmaceutical Co., Ltd. successfully passed an on-site inspection by the Russian Federal Ministry of Industry and Trade's drug inspection authority from July 30 to August 1, 2025 [2] - The company received the Good Manufacturing Practice (GMP) certificate from the Russian Federal Ministry of Industry and Trade, confirming compliance with the Eurasian Economic Union's pharmaceutical production standards [2]